6:01 PM
 | 
Jun 25, 2008
 |  BC Extra  |  Company News

MediQuest's MQX-503 gets Priority Review

FDA accepted for filing and granted Priority Review to an NDA from MediQuest...

Read the full 48 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >